WuXi AppTec

WuXi AppTec is a dominant, highly influential global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides a remarkably broad and deeply integrated portfolio of R&D and manufacturing services to the pharmaceutical and healthcare industries worldwide. Headquartered in Shanghai, China, WuXi AppTec has fundamentally revolutionized the global outsourcing model by offering a highly unique ‘open-access’ capability and technology platform. This platform dynamically empowers anyone—from massive global pharma conglomerates to nimble, virtual biotech startups—to discover, develop, and manufacture therapeutic interventions efficiently.

The company is globally renowned for its immense scale, speed, and scientific firepower, employing tens of thousands of highly trained scientists across massive, state-of-the-art campuses in Asia, the US, and Europe. Their comprehensive services seamlessly cover small molecule discovery, rigorous preclinical testing, global clinical trial operations, and massive commercial manufacturing. WuXi AppTec is particularly famous for its highly successful “Follow the Molecule” strategy, seamlessly guiding a client’s drug from a mere concept in medicinal chemistry all the way through to commercial scale-up without the client ever needing to transfer knowledge to a different vendor.

Additionally, through its specialized subsidiary WuXi Advanced Therapies (WuXi ATU), it provides cutting-edge Contract Testing, Development, and Manufacturing Organization (CTDMO) services specifically for complex cell and gene therapies. Its core business segments—WuXi Chemistry, WuXi Biology, and WuXi Testing—operate in a highly coordinated manner to eliminate developmental handoffs and reduce delays.

By maintaining rigorous global quality standards and enabling over 6,000 customers across more than 30 countries, WuXi AppTec’s rapid turnaround, cost-effectiveness, and massive scale make it a critical engine for global drug development. Guided by its foundational vision that “every drug can be made and every disease can be treated,” the company continues to act as an indispensable catalyst for translating scientific discoveries into life-saving treatments worldwide.